S. Hoa

发表

Towards developing criteria for scleroderma renal crisis: A scoping review.

M. Hudson, C. Denton, S. Hoa, 2017, Autoimmunity reviews.

Recognising the spectrum of scleromyositis: HEp-2 ANA patterns allow identification of a novel clinical subset with anti-SMN autoantibodies

M. Hudson, M. Fritzler, I. Targoff, 2020, RMD Open.

Factors associated with fears due to COVID-19: A Scleroderma Patient-centered Intervention Network (SPIN) COVID-19 cohort study

Richard S. Henry, M. Suarez‐Almazor, D. Rice, 2020, Journal of Psychosomatic Research.

Randomized feasibility trial of the Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program

Richard S. Henry, M. Suarez‐Almazor, B. Levis, 2022, Pilot and Feasibility Studies.

Describing and expanding the clinical phenotype of anti-MDA5-associated rapidly progressive interstitial lung disease: case series of nine Canadian patients and literature review

M. Fritzler, I. Targoff, S. Hoa, 2018, Scandinavian journal of rheumatology.

Association between immunosuppressive therapy and course of mild interstitial lung disease in systemic sclerosis.

R. Steele, M. Hudson, M. Baron, 2019, Rheumatology.

Rheumatic immune-related adverse events associated with cancer immunotherapy: A nationwide multi-center cohort.

M. Hudson, S. Jamal, R. Rottapel, 2020, Autoimmunity reviews.

Risk of rheumatic disease in breast implant users: a qualitative systematic review.

M. Hudson, S. C. Nicolaidis, S. Hoa, 2021, Gland surgery.

Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associations

M. Mayes, M. Hudson, M. Baron, 2016, Medicine.

Preexisting autoimmune disease and immune-related adverse events associated with anti-PD-1 cancer immunotherapy: a national case series from the Canadian Research Group of Rheumatology in Immuno-Oncology

M. Hudson, S. Jamal, R. Rottapel, 2021, Cancer Immunology, Immunotherapy.

Mortality and morbidity in scleroderma renal crisis: A systematic literature review

M. Hudson, S. Hoa, Hyein Kim, 2020, Journal of scleroderma and related disorders.

Capillary pathology with prominent basement membrane reduplication is the hallmark histopathological feature of scleromyositis

M. Hudson, M. Fritzler, J. Karamchandani, 2022, Neuropathology and applied neurobiology.

Randomized controlled trial of an internet-based self-guided hand exercise program to improve hand function in people with systemic sclerosis: the Scleroderma Patient-centered Intervention Network Hand Exercise Program (SPIN-HAND) trial

Richard S. Henry, M. Suarez‐Almazor, B. Levis, 2022, Trials.

Statin-induced anti-HMGCR myopathy: successful therapeutic strategies for corticosteroid-free remission in 55 patients

M. Hudson, S. Hussein, J. Raynauld, 2020, Arthritis Research & Therapy.

Criteria for the pathogenicity of anticentromere (anti–CENP‐B) autoantibodies in systemic sclerosis: comment on the article by van Leeuwen et al

M. Koenig, S. Hoa, J. Senécal, 2022, Arthritis & rheumatology.

The Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program: protocol for a two-arm parallel partially nested randomized controlled feasibility trial with progression to full-scale trial

Richard S. Henry, M. Suarez‐Almazor, B. Levis, 2021, Trials.

Changes in mental health symptoms from pre-COVID-19 to COVID-19 among participants with systemic sclerosis from four countries: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study

Richard S. Henry, M. Suarez‐Almazor, D. Rice, 2020, Journal of Psychosomatic Research.

Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patients

Richard S. Henry, M. Suarez‐Almazor, D. Rice, 2020, Journal of Psychosomatic Research.

Pathogenic roles of autoantibodies in systemic sclerosis: Current understandings in pathogenesis

M. Koenig, S. Hoa, J. Senécal, 2019, Journal of scleroderma and related disorders.

Histopathological features of systemic sclerosis-associated myopathy: A scoping review.

M. Hudson, M. Fritzler, B. Ellezam, 2021, Autoimmunity reviews.

Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease

R. Steele, M. Hudson, K. Schwartzman, 2018, European Respiratory Review.

Generation of a Core Set of Items to Develop Classification Criteria for Scleroderma Renal Crisis Using Consensus Methodology

M. Hudson, M. Baron, C. Ghossein, 2019, Arthritis & rheumatology.

Cutaneous Lymphangiectasia in Systemic Sclerosis

M. Hudson, S. Hoa, V. Leclair, 2017, Arthritis & rheumatology.

Pain levels and associated factors in the Scleroderma Patient-centered Intervention Network (SPIN) cohort: a multicentre cross-sectional study.

Richard S. Henry, M. Suarez‐Almazor, B. Levis, 2021, The Lancet. Rheumatology.

Richard S. Henry, M. Suarez‐Almazor, D. Rice, 2020, Journal of psychosomatic research.

Physical and Psychological Comfort Evaluation of Maternity Support Garments

S. Hoa, W. Yua, Y. Lia, 2007 .

Richard S. Henry, M. Suarez‐Almazor, B. Levis, 2021, Trials.

ASSOCIATION BETWEEN IMMUNOSUPPRESSIVE THERAPY AND INCIDENT RISK OF INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS.

R. Steele, M. Hudson, M. Baron, 2021, Chest.

Patterns of patient-reported symptoms and association with sociodemographic and systemic sclerosis disease characteristics: a scleroderma Patient-centered Intervention Network (SPIN) Cohort cross-sectional study

Richard S. Henry, M. Suarez‐Almazor, B. Levis, 2023, EClinicalMedicine.

Association between gastroprotective agents and risk of incident interstitial lung disease in systemic sclerosis.

R. Steele, M. Hudson, M. Baron, 2021, Respiratory Medicine.

Immunosuppression does not prevent severe gastrointestinal tract involvement in systemic sclerosis.

M. Hudson, M. Baron, Mianbo Wang, 2021, Clinical and experimental rheumatology.

Association between autoantibodies in systemic sclerosis and cancer in a national registry.

M. Hudson, M. Baron, Mianbo Wang, 2021, Rheumatology.

AB1768-HPR SAFETY AND EFFICACY OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH RHEUMATIC AUTOIMMUNE DISEASE: EXPERIENCE FROM THE CANADIAN RESEARCH GROUP OF RHEUMATOLOGY IN IMMUNO-ONCOLOGY (CANRIO)

M. Hudson, S. Jamal, S. Hoa, 2023, Annals of the Rheumatic Diseases.

SAT0598 RHEUMATIC IMMUNE RELATED ADVERSE EVENTS ASSOCIATED WITH CANCER IMMUNOTHERAPY: A NATIONWIDE MULTI-CENTER CANADIAN COHORT FROM THE CANADIAN RESEARCH GROUP OF RHEUMATOLOGY IN IMMUNO-ONCOLOGY (CANRIO)

M. Hudson, S. Jamal, J. Pope, 2019 .

A qualitative interview study exploring the psychological health impacts of the SPIN-CHAT program among people with systemic sclerosis at the onset of COVID-19: perceptions of trial participants and research team members

Richard S. Henry, M. Suarez‐Almazor, D. Rice, 2023, Disability and rehabilitation.